Immediate Opening for a Postdoctoral Fellow in the NCI T32 Training Program in Translational Genomics and Precision Medicine

The University of Texas M. D. Anderson Cancer Center

Houston, TX

ID: 7085898
Posted: September 22, 2021
Application Deadline: October 1, 2021

Job Description

ELIGIBILITY REQUIREMENTS: Postdoctoral fellows must be U.S. citizens or have permanent residence

The NCI T32 in Translational Genomics and Precision Medicine in Cancer (TGP) training program invites applicants for its postdoctoral training program at the University of Texas MD Anderson Cancer Center. The T32 program was developed in response to a new revolution of Big Data and the need for scientists to be trained in the discovery, integration and interpretation of translational genomics for precision medicine. The training plan allows qualified predoctoral or postdoctoral candidates to be educated and trained in-depth and breadth in state-of-the-art areas of translational genomics and precision medicine related to cancer. The goal is to educate and train the next generation of scientists to understand broadly their role in driving precision medicine through discovery science and development of novel genomic analytical tools necessary to power this application in the clinical setting. In addition to a mentored research experience by one of our outstanding training faculty, both PhD candidates and postdoctoral fellows are expected to gain interdisciplinary training in core competency areas critical to the future of translational genomic science.

Core Competencies for the program include a depth and breadth of knowledge in 5 areas: 1) translational cancer research, to gain exposure to mechanistic studies in translational research and their importance to the human organism; 2) precision medicine to gain experience in state-of-the-art ways to diagnose and target treatment of cancer patients based on genomic or immunogenetic profiles; 3) translational genetics and genomics, to gain competency in translational genomics needed for future understanding and implementation of cancer precision medicine; 4) bioinformatics, to learn how to read and interpret large omics datasets; and, 5) exposure to relevant tumor boards (monthly) and to industrial collaborations with academic faculty mentors on large scale genomic applications in cancer precision medicine.

ELIGIBILITY REQUIREMENTS: Postdoctoral fellows must be U.S. citizens or have permanent residence.

T32 Departments & Faculty Mentors:

Translational Molecular Pathology
• Krishna Bhat, PhD
• Humam Kadara, PhD
• Ann Killary, PhD
• Larry Kwong PhD
• Sue-Hwa Lin, PhD
• Sendurai Mani, PhD
• Subrata Sen, PhD
• Rama Soundararajan, PhD
• Ignacio Wistuba, MD

Clinical Cancer Prevention
• Florencia McAllister, MD
• Eduardo Vilar-Sanchez, MD

Epidemiology
• Paul Scheet, PhD

GI Medical Oncology
• Scott Kopetz, MD, PhD

Genetics
• Nick Navin, PhD
• Ralf Krahe, PhD
• Sadhan Majumder, PhD

Bioinformatics & Computational Biology
• Han Liang, PhD

Hematopathology and Pathology
• Jason Huse, MD, PhD
• Timothy McDonnell, MD, PhD
• Anirban Maitra, MD, MBBS

Encouraging Diversity: The training program is committed to ensuring diversity in selecting outstanding fellows for the program. Minority, disadvantaged or disabled applicants are encouraged to apply.

For more information please contact the T32 Leadership Team:
Ann Killary, PhD, Professor, Translational Molecular Pathology, akillary@mdanderson.org
Ignacio Wistuba, MD, Chair, Translational Molecular Pathology, iiwistuba@mdanderson.org
Krishna Bhat, PhD, Associate Professor, Translational Molecular Pathology, kbhat@mdanderson.org
Martha L. Burns, Education Program Coordinator, Translational Molecular Pathology, mlburns1@mdanderson.org


It is the policy of The University of Texas MD Anderson Cancer Center to provide equal employment opportunity without regard to race, color, religion, age, national origin, sex, gender, sexual orientation, gender identity/expression, disability, protected veteran status, genetic information, or any other basis protected by institutional policy or by federal, state or local laws unless such distinction is required by law. http://www.mdanderson.org/about-us/legal-and-policy/legal-statements/eeo-affirmative-action.html



 

Apply Now

Please mention to the employer that you saw this ad on UniversityJobs.com